RxDoctor Payments Data

James Owens, MD

Family Medicine · Jarvisburg, NCNPI 1962549345

Payments from drug & device makers

$751in general payments, 2019–2025

Across 42 payments — averaging $17.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$220
  • AbbVie$132
  • Novartis$105
  • Pfizer$63
  • Lilly USA, LLC$61
  • Johnson & Johnson$39
  • plus $130 from 8 others

What the payments were for

  • Food & beverage$60681%
  • Education$14519%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$751 in reported general payments places this provider in the 65th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$173,797
Medicare patients
601
Services billed
2,683

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban452$182,285
JardianceEmpagliflozin188$119,227
XareltoRivaroxaban161$85,055
Trelegy ElliptaFluticasone/Umeclidin/Vilanter107$61,729
OzempicSemaglutide59$61,539
JanuviaSitagliptin Phosphate84$43,663
XifaxanRifaximin42$43,064
OtezlaApremilast41$38,471
MounjaroTirzepatide36$36,373
TrulicityDulaglutide33$32,098
LinzessLinaclotide28$20,261
SymbicortBudesonide/Formoterol Fumarate57$15,662
Spiriva HandihalerTiotropium Bromide21$15,155
Potassium Chloride350$14,676
Spiriva RespimatTiotropium Bromide17$14,632

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$63$182,285452 claims
Johnson & JohnsonXarelto$39$85,055161 claims
Lilly USA, LLCMounjaro, Trulicity$61$68,47069 claims
AmgenOtezla$16$38,47141 claims
AbbVieLinzess, Savella, Creon$132$36,592109 claims
Astellas Pharma US IncMyrbetriq$220$11,14315 claims
Sumitomo Pharma America, Inc.Gemtesa$15$10,24723 claims
NovartisEntresto$105$7,12225 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Jarvisburg

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →